Dark Forest Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,433
| Closed | -$380K | – | 1400 |
|
|
2025
Q1 | $380K | Buy |
3,433
+1,808
| +111% | +$200K | 0.02% | 1003 |
|
|
2024
Q4 | $222K | Buy |
+1,625
| New | +$222K | 0.03% | 785 |
|
|
2023
Q4 | – | Sell |
-8,864
| Closed | -$997K | – | 884 |
|
|
2023
Q3 | $997K | Buy |
+8,864
| New | +$997K | 0.08% | 409 |
|
|
2023
Q2 | – | Sell |
-1,591
| Closed | -$161K | – | 1266 |
|
|
2023
Q1 | $161K | Buy |
+1,591
| New | +$161K | 0.04% | 486 |
|
|
2021
Q4 | – | Sell |
-106
| Closed | -$10K | – | 1665 |
|
|
2021
Q3 | $10K | Buy |
+106
| New | +$10K | ﹤0.01% | 988 |
|